Company Information

  

Address: 9980 HUENNEKENS ST.
SUITE 100 
City: SAN DIEGO 
State: CA 
Zip Code: 92121 
Telephone: 858-794-1400 

Description of Business

Primary SIC Code: 3841
(As filed with the SEC)  

We are an in-vitro diagnostic company based in San Diego, California. We have commercialized a proprietary tear testing platform, the TearLabĀ® Osmolarity System that enables eye care practitioners to test for highly sensitive and specific biomarkers using nanoliters of tear film at the point-of-care. Our first product measures tear film osmolarity for the diagnosis of Dry Eye Disease or DED. Our results are included in our financial statements, which are included under Item 8 to this Annual Report on Form 10-K. TearLab Research, Inc. TearLab Research, Inc. ("TearLab Research"), our wholly-owned subsidiary, develops technologies to enable eye care practitioners to test a wide range of biomarkers (chemistries, metabolites, genes and proteins) at the point-of-care. Commercializing that tear testing platform is now the focus of our business.  ... More ...  

Per Share Overview

Date 12-mos Rolling EPS Dividend P/E Ratio
06/2017-4.00NAN/E
03/2017-2.97NAN/E
12/2016-42.90NAN/E
06/2016-85.00NAN/E

Key Financial Ratios and Statistics

FYE: 12/31

Profitability 2016 Leverage 2016
Net Inc/Comm Equity-0.04Total Liab/Total Assets1.21
Net Inc/Total Assets-0.75Total Liab/Inv Cap1.56
Net Inc/Inv Cap-0.96Total Liab/Comm Equity0.06
Pretax Inc/Net Sales-0.71Interest Coverage Ratio-3.98
Net Inc/Net Sales-0.71Curr Debt/EquityNA
Cash Flow/Net Sales-0.45LTD/Equity-4.62
SG&A/NetSales0.91Total Debt/Equity-4.62
Asset Utilization   Liquidity  
Net Receivables Turnover10.57Quick Ratio3.22
Inventory Turnover3.44Current Ratio3.76
Inventory Day Sales0.01Net Rec/Curr Assets0.10
Net Sales/Work Cap1.72Inv/Curr Assets0.14
Net Sales/PP&E6.71  

Income Statement (Millions)

  6/30/2017 3/31/2017 12/31/2016 9/30/2016
Total Revenues(Net Sales) 7.01 6.70 7.12 7.22
Cost of Goods Sold 3.13 3.01 3.11 3.09
Selling & Admin Exps 5.61 5.52 4.86 5.71
Operating Income -2.84 -3.39 -3.30 -2.94
Interest Exp NA NA 4.00 NA
Pretax Income -3.89 -4.42 -4.34 -3.98
Other Income -0.01 -0.00 -0.01 -0.00
Net Income Bef Extraordinary ... NA NA NA NA
Net Income -3.89 -4.42 -4.34 -3.98

Balance Sheet (Millions)

Assets 6/30/2017 3/31/2017 12/31/2016 9/30/2016
Cash & Short Term Investments 10.24 13.03 15.47 17.55
Receivables - Total 2.13 2.27 2.28 2.41
Inventories - Total 2.88 3.32 3.19 3.40
Total Current Assets 16.33 19.84 22.17 24.20
Net Property, Plant & Equipment 3.72 3.88 4.18 4.71
Total Assets 20.19 23.98 26.63 29.47
Liabilities        
Accounts Payable 6.22 6.83 5.82 5.10
Debt in Current Liabilities NA NA NA NA
Total Current Liabilities 6.28 6.90 5.90 5.21
Long-Term Debt 27.37 26.91 26.45 25.99
Total Liabilities 33.65 33.80 32.35 31.20
Stockholder's Equity        
Minority Interest NA NA NA NA
Preferred Stock 0.00 0.00 0.00 1.91
Common Stock 0.01 0.01 0.05 0.05
Retained Earnings -521.02 -517.13 -512.71 -508.37
Treasury Stock NA NA NA NA
Total Stockholders' Equity -13.47 -9.82 -5.72 -1.72
Total Liabilities and Stockholders' Equity 20.19 23.98 26.63 29.47

Cash Flow Summary (Millions)

Categories 6/30/2017 3/31/2017 12/31/2016 9/30/2016
Net Cash Provided by Operating Activities -2.45 -2.25 -1.82 -2.27
Net Cash Provided by Investing Activities -0.35 -0.22 -0.26 -0.33
Net Cash Provided by Financing Activities 0.00 0.03 0.00 0.04

Annual Summary Data (Millions)

Year Sales Net Income EPS
12/20123.96-19.31--
12/201314.64-28.99--
12/201419.72-23.72--
12/201525.16-33.23--
12/201628.01-19.92-42.90
Growth Rates63.09----

Stock Ownership

Type Date(Q,M) No. Owners Shares Held (000s) % Own
Institutional09/30/17261,14219.89




Report Date : 10/16/2017

Powered By Edgar Online © 2017EDGAR®Online, a division of Donnelley Financial Solutions. EDGAR® is a federally registered trademark of the U.S. Securities and Exchange Commission. EDGAR Online is not affiliated with or approved by the U.S. Securities and Exchange Commission.